Dayakar A, Chandrasekaran S, Veronica J, Bharadwaja V, Maurya R
    
    
    Sci Rep. 2017; 7(1):14664.
  
  
    PMID: 29116252
    
          PMC: 5676676.
    
          DOI: 10.1038/s41598-017-15288-7.
      
 
                                  
  
    Hammami A, Charpentier T, Smans M, Stager S
    
    
    PLoS Pathog. 2015; 11(6):e1004938.
  
  
    PMID: 26046638
    
          PMC: 4457842.
    
          DOI: 10.1371/journal.ppat.1004938.
      
 
                                  
  
    Bogdan C
    
    
    Front Cell Infect Microbiol. 2012; 2:69.
  
  
    PMID: 22919660
    
          PMC: 3417408.
    
          DOI: 10.3389/fcimb.2012.00069.
      
 
                                  
  
    Stanley A, De Labastida Rivera F, Haque A, Sheel M, Zhou Y, Amante F
    
    
    PLoS Pathog. 2011; 7(10):e1002279.
  
  
    PMID: 21998581
    
          PMC: 3188526.
    
          DOI: 10.1371/journal.ppat.1002279.
      
 
                                  
  
    Carrion J, Folgueira C, Soto M, Fresno M, Requena J
    
    
    Parasit Vectors. 2011; 4:150.
  
  
    PMID: 21794145
    
          PMC: 3199857.
    
          DOI: 10.1186/1756-3305-4-150.
      
 
                              
              
                              
                                      
  Compartment-specific remodeling of splenic micro-architecture during experimental visceral leishmaniasis.
  
    Yurdakul P, Dalton J, Beattie L, Brown N, Erguven S, Maroof A
    
    
    Am J Pathol. 2011; 179(1):23-9.
  
  
    PMID: 21703391
    
          PMC: 3123882.
    
          DOI: 10.1016/j.ajpath.2011.03.009.
      
 
                                          
                                                          
  Innate killing of Leishmania donovani by macrophages of the splenic marginal zone requires IRF-7.
  
    Phillips R, Svensson M, Aziz N, Maroof A, Brown N, Beattie L
    
    
    PLoS Pathog. 2010; 6(3):e1000813.
  
  
    PMID: 20300600
    
          PMC: 2837405.
    
          DOI: 10.1371/journal.ppat.1000813.
      
 
                                          
                                                          
  Cytokines and their STATs in cutaneous and visceral leishmaniasis.
  
    Cummings H, Tuladhar R, Satoskar A
    
    
    J Biomed Biotechnol. 2010; 2010:294389.
  
  
    PMID: 20300429
    
          PMC: 2840379.
    
          DOI: 10.1155/2010/294389.
      
 
                                          
                                                          
  A Leishmania infantum cytosolic tryparedoxin activates B cells to secrete interleukin-10 and specific immunoglobulin.
  
    Cabral S, Silvestre R, Santarem N, Tavares J, Silva A, Cordeiro-da-Silva A
    
    
    Immunology. 2007; 123(4):555-65.
  
  
    PMID: 18028371
    
          PMC: 2433312.
    
          DOI: 10.1111/j.1365-2567.2007.02725.x.
      
 
                                          
                                                          
  Temporal regulation of interleukin-12p70 (IL-12p70) and IL-12-related cytokines in splenic dendritic cell subsets during Leishmania donovani infection.
  
    Maroof A, Kaye P
    
    
    Infect Immun. 2007; 76(1):239-49.
  
  
    PMID: 17998312
    
          PMC: 2223655.
    
          DOI: 10.1128/IAI.00643-07.
      
 
                                          
                                                          
  Chronic Leishmania donovani infection promotes bystander CD8+-T-cell expansion and heterologous immunity.
  
    Polley R, Sanos S, Prickett S, Haque A, Kaye P
    
    
    Infect Immun. 2005; 73(12):7996-8001.
  
  
    PMID: 16299292
    
          PMC: 1307086.
    
          DOI: 10.1128/IAI.73.12.7996-8001.2005.
      
 
                                          
                                                          
  Invariant NKT cells are essential for the regulation of hepatic CXCL10 gene expression during Leishmania donovani infection.
  
    Svensson M, Zubairi S, Maroof A, Kazi F, Taniguchi M, Kaye P
    
    
    Infect Immun. 2005; 73(11):7541-7.
  
  
    PMID: 16239557
    
          PMC: 1273891.
    
          DOI: 10.1128/IAI.73.11.7541-7547.2005.
      
 
                                          
                                                          
  Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy.
  
    Murray H, Lu C, Mauze S, Freeman S, Moreira A, Kaplan G
    
    
    Infect Immun. 2002; 70(11):6284-93.
  
  
    PMID: 12379707
    
          PMC: 130311.
    
          DOI: 10.1128/IAI.70.11.6284-6293.2002.
      
 
                                          
                                                          
  A role for tumor necrosis factor-alpha in remodeling the splenic marginal zone during Leishmania donovani infection.
  
    Engwerda C, Ato M, Cotterell S, Mynott T, Tschannerl A, Kaye P
    
    
    Am J Pathol. 2002; 161(2):429-37.
  
  
    PMID: 12163368
    
          PMC: 1850733.
    
          DOI: 10.1016/s0002-9440(10)64199-5.
      
 
                                          
                                                          
  Locally up-regulated lymphotoxin alpha, not systemic tumor necrosis factor alpha, is the principle mediator of murine cerebral malaria.
  
    Engwerda C, Mynott T, Sawhney S, de Souza J, Bickle Q, Kaye P
    
    
    J Exp Med. 2002; 195(10):1371-7.
  
  
    PMID: 12021316
    
          PMC: 2193758.
    
          DOI: 10.1084/jem.20020128.
      
 
                                          
                                                          
  Tissue granuloma structure-function in experimental visceral leishmaniasis.
  
    Murray H
    
    
    Int J Exp Pathol. 2001; 82(5):249-67.
  
  
    PMID: 11703536
    
          PMC: 2517779.
    
          DOI: 10.1046/j.1365-2613.2001.00199.x.
      
 
                                          
                                                          
  Clinical and experimental advances in treatment of visceral leishmaniasis.
  
    Murray H
    
    
    Antimicrob Agents Chemother. 2001; 45(8):2185-97.
  
  
    PMID: 11451673
    
          PMC: 90630.
    
          DOI: 10.1128/AAC.45.8.2185-2197.2001.
      
 
                                          
                                                          
  Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
  
    Escobar P, Yardley V, Croft S
    
    
    Antimicrob Agents Chemother. 2001; 45(6):1872-5.
  
  
    PMID: 11353640
    
          PMC: 90560.
    
          DOI: 10.1128/AAC.45.6.1872-1875.2001.
      
 
                                          
                                                          
  Enhanced hematopoietic activity accompanies parasite expansion in the spleen and bone marrow of mice infected with Leishmania donovani.
  
    Cotterell S, Engwerda C, Kaye P
    
    
    Infect Immun. 2000; 68(4):1840-8.
  
  
    PMID: 10722572
    
          PMC: 97356.
    
          DOI: 10.1128/IAI.68.4.1840-1848.2000.